Granulomatosis With Polyangiitis

PR3-AAV Resilient Remission or PRRR

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach

Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis

Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis

TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis

Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)

Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis

Study of Salvage Therapy to Treat Patients with Granulomatosis with Polyangiitis

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.

PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis

Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis

Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers

Rituximab and Belimumab Combination Therapy in PR3 Vasculitis